Exercise Intolerance as a Clinical Red Flag For Childhood-Onset Mitochondrial Diseases : A Narrative Review
DOI:
https://doi.org/10.12775/QS.2026.72.75359Keywords
mitochondrial diseases, mitochondrial disorders, mitochondrial myopathies, exercise intolerance, physical activity, pediatric, childhood, diagnosisAbstract
Background: Childhood-onset mitochondrial diseases comprise a clinically and genetically heterogeneous group of inherited disorders in which impaired oxidative phosphorylation predominantly affects tissues with high energy demands. Exercise intolerance is a common but nonspecific manifestation that may be overlooked or attributed to other conditions, contributing to delayed diagnosis. This narrative review aims to summarize the current evidence regarding exercise intolerance as a potential clinical red flag for childhood-onset mitochondrial diseases.
Methods: A narrative literature review was conducted using the PubMed/MEDLINE database. English-language articles published between 2010 and 2026 were identified using keywords related to mitochondrial diseases, exercise intolerance, diagnosis, and pediatric populations. Additional relevant studies were identified through backward citation searching.
Results: Current evidence suggests that exercise intolerance frequently represents one of the earliest manifestations of childhood-onset mitochondrial diseases. Its diagnostic significance increases when accompanied by neurological or multisystem manifestations together with supportive laboratory or neuroimaging abnormalities, warranting further metabolic and genetic evaluation.
Conclusions: Exercise intolerance should be recognized as an important clinical red flag for childhood-onset mitochondrial diseases, particularly when associated with additional neurological or multisystem features. Early clinical recognition followed by appropriate metabolic and genetic evaluation may reduce diagnostic delay, facilitate molecular diagnosis, and improve patient management.
References
Berardo, A., DiMauro, S., & Hirano, M. (2010). A diagnostic algorithm for metabolic myopathies. Current Neurology and Neuroscience Reports, 10(2), 118–126. https://doi.org/10.1007/s11910-010-0096-4
Bermejo-Guerrero, L., de Fuenmayor-Fernández de la Hoz, C. P., Guerrero-Molina, M. P., Martín-Jiménez, P., Blázquez, A., Serrano-Lorenzo, P., Lora, D., Morales-Conejo, M., González-Martínez, I., López-Jiménez, E. A., Martín, M. A., & Domínguez-González, C. (2023). Serum GDF-15 Levels Accurately Differentiate Patients with Primary Mitochondrial Myopathy, Manifesting with Exercise Intolerance and Fatigue, from Patients with Chronic Fatigue Syndrome. Journal of Clinical Medicine, 12(6), 2435. https://doi.org/10.3390/jcm12062435
Conley, K. E. (2016). Mitochondria to motion: Optimizing oxidative phosphorylation to improve exercise performance. The Journal of Experimental Biology, 219(2), 243–249. https://doi.org/10.1242/jeb.126623
Conti, F., Di Martino, S., Drago, F., Bucolo, C., Micale, V., Montano, V., Siciliano, G., Mancuso, M., & Lopriore, P. (2023). Red Flags in Primary Mitochondrial Diseases: What Should We Recognize? International Journal of Molecular Sciences, 24(23), 16746. https://doi.org/10.3390/ijms242316746
Danti, F. R., Invernizzi, F., Moroni, I., Garavaglia, B., Nardocci, N., & Zorzi, G. (2021). Pediatric Paroxysmal Exercise-Induced Neurological Symptoms: Clinical Spectrum and Diagnostic Algorithm. Frontiers in Neurology, 12, 658178. https://doi.org/10.3389/fneur.2021.658178
Davis, R. L., Liang, C., & Sue, C. M. (2016). A comparison of current serum biomarkers as diagnostic indicators of mitochondrial diseases. Neurology, 86(21), 2010–2015. https://doi.org/10.1212/WNL.0000000000002705
Gorman, G. S., Chinnery, P. F., DiMauro, S., Hirano, M., Koga, Y., McFarland, R., Suomalainen, A., Thorburn, D. R., Zeviani, M., & Turnbull, D. M. (2016). Mitochondrial diseases. Nature Reviews Disease Primers, 2(1), 16080. https://doi.org/10.1038/nrdp.2016.80
Hargreaves, M., & Spriet, L. L. (2020). Skeletal muscle energy metabolism during exercise. Nature Metabolism, 2(9), 817–828. https://doi.org/10.1038/s42255-020-0251-4
Heath, O., Feichtinger, R. G., Achleitner, M. T., Hofbauer, P., Mayr, D., Merkevicius, K., Spenger, J., Steinbrücker, K., Steindl, C., Tiefenthaler, E., Mayr, J. A., & Wortmann, S. B. (2025). Mitochondrial disorder diagnosis and management– what the pediatric neurologist wants to know. European Journal of Paediatric Neurology, 54, 75–88. https://doi.org/10.1016/j.ejpn.2024.10.009
Jeppesen, T. D., Madsen, K. L., Poulsen, N. S., Løkken, N., & Vissing, J. (2021). Exercise Testing, Physical Training and Fatigue in Patients with Mitochondrial Myopathy Related to mtDNA Mutations. Journal of Clinical Medicine, 10(8), 1796. https://doi.org/10.3390/jcm10081796
Ji, X., Zhao, L., Ji, K., Zhao, Y., Li, W., Zhang, R., Hou, Y., Lu, J., & Yan, C. (2017). Growth Differentiation Factor 15 Is a Novel Diagnostic Biomarker of Mitochondrial Diseases. Molecular Neurobiology, 54(10), 8110–8116. https://doi.org/10.1007/s12035-016-0283-7
Koenig, M. K. (2008). Presentation and Diagnosis of Mitochondrial Disorders in Children. Pediatric Neurology, 38(5), 305–313. https://doi.org/10.1016/j.pediatrneurol.2007.12.001
Lehtonen, J. M., Forsström, S., Bottani, E., Viscomi, C., Baris, O. R., Isoniemi, H., Höckerstedt, K., Österlund, P., Hurme, M., Jylhävä, J., Leppä, S., Markkula, R., Heliö, T., Mombelli, G., Uusimaa, J., Laaksonen, R., Laaksovirta, H., Auranen, M., Zeviani, M., … Suomalainen, A. (2016). FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders. Neurology, 87(22), 2290–2299. https://doi.org/10.1212/WNL.0000000000003374
Mancuso, M., Angelini, C., Bertini, E., Carelli, V., Comi, G. P., Minetti, C., Moggio, M., Mongini, T., Servidei, S., Tonin, P., Toscano, A., Uziel, G., Zeviani, M., Siciliano, G., & Nation-wide Italian Collaborative Network of Mitochondrial Diseases. (2012). Fatigue and exercise intolerance in mitochondrial diseases. Literature revision and experience of the Italian Network of mitochondrial diseases. Neuromuscular Disorders: NMD, 22 Suppl 3(3–3), S226-229. https://doi.org/10.1016/j.nmd.2012.10.012
Morava, E., van den Heuvel, L., Hol, F., de Vries, M. C., Hogeveen, M., Rodenburg, R. J., & Smeitink, J. A. M. (2006). Mitochondrial disease criteria. Neurology, 67(10), 1823–1826. https://doi.org/10.1212/01.wnl.0000244435.27645.54
Morovat, A., Weerasinghe, G., Nesbitt, V., Hofer, M., Agnew, T., Quaghebeur, G., Sergeant, K., Fratter, C., Guha, N., Mirzazadeh, M., & Poulton, J. (2017). Use of FGF-21 as a Biomarker of Mitochondrial Disease in Clinical Practice. Journal of Clinical Medicine, 6(8), 80. https://doi.org/10.3390/jcm6080080
Munnich, A., Rötig, A., Chretien, D., Cormier, V., Bourgeron, T., Bonnefont, J. P., Saudubray, J. M., & Rustin, P. (1996). Clinical presentation of mitochondrial disorders in childhood. Journal of Inherited Metabolic Disease, 19(4), 521–527. https://doi.org/10.1007/BF01799112
Parikh, S., Goldstein, A., Koenig, M. K., Scaglia, F., Enns, G. M., Saneto, R., Anselm, I., Cohen, B. H., Falk, M. J., Greene, C., Gropman, A. L., Haas, R., Hirano, M., Morgan, P., Sims, K., Tarnopolsky, M., Hove, J. L. K. V., Wolfe, L., & DiMauro, S. (2015). Diagnosis and management of mitochondrial disease: A consensus statement from the Mitochondrial Medicine Society. Genetics in Medicine, 17(9), 689–701. https://doi.org/10.1038/gim.2014.177
Porcelli, S., Grassi, B., Poole, D. C., & Marzorati, M. (2019). Exercise intolerance in patients with mitochondrial myopathies: Perfusive and diffusive limitations in the O2 pathway. Current Opinion in Physiology, Exercise Physiology, 10, 202–209. https://doi.org/10.1016/j.cophys.2019.05.011
Rahman, S. (2020). Mitochondrial disease in children. Journal of Internal Medicine, 287(6), 609–633. https://doi.org/10.1111/joim.13054
Suomalainen, A., Elo, J. M., Pietiläinen, K. H., Hakonen, A. H., Sevastianova, K., Korpela, M., Isohanni, P., Marjavaara, S. K., Tyni, T., Kiuru-Enari, S., Pihko, H., Darin, N., Õunap, K., Kluijtmans, L. A., Paetau, A., Buzkova, J., Bindoff, L. A., Annunen-Rasila, J., Uusimaa, J., … Tyynismaa, H. (2011). FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: A diagnostic study. The Lancet Neurology, 10(9), 806–818. https://doi.org/10.1016/S1474-4422(11)70155-7
Taivassalo, T., Jensen, T. D., Kennaway, N., DiMauro, S., Vissing, J., & Haller, R. G. (2003). The spectrum of exercise tolerance in mitochondrial myopathies: A study of 40 patients. Brain: A Journal of Neurology, 126(Pt 2), 413–423. https://doi.org/10.1093/brain/awg028
Tarnopolsky, M. (2004). Exercise testing as a diagnostic entity in mitochondrial myopathies. Mitochondrion, Mitochondrial Medicine - Developing the Scientific Basis to Medical Management of Mitochondrial Disease, 4(5), 529–542. https://doi.org/10.1016/j.mito.2004.07.011
Toscano, A., Barca, E., & Musumeci, O. (2017). Update on diagnostics of metabolic myopathies. Current Opinion in Neurology, 30(5), 553–562. https://doi.org/10.1097/WCO.0000000000000483
Vissing, J., Gansted, U., & Quistorff, B. (2001). Exercise intolerance in mitochondrial myopathy is not related to lactic acidosis. Annals of Neurology, 49(5), 672–676.
Wen, H., Deng, H., Li, B., Chen, J., Zhu, J., Zhang, X., Yoshida, S., & Zhou, Y. (2025). Mitochondrial diseases: From molecular mechanisms to therapeutic advances. Signal Transduction and Targeted Therapy, 10(1), 9. https://doi.org/10.1038/s41392-024-02044-3
Witters, P., Saada, A., Honzik, T., Tesarova, M., Kleinle, S., Horvath, R., Goldstein, A., & Morava, E. (2018). Revisiting mitochondrial diagnostic criteria in the new era of genomics. Genetics in Medicine, 20(4), 444–451. https://doi.org/10.1038/gim.2017.125
Wortmann, S. B., Mayr, J. A., Nuoffer, J. M., Prokisch, H., & Sperl, W. (2017). A Guideline for the Diagnosis of Pediatric Mitochondrial Disease: The Value of Muscle and Skin Biopsies in the Genetics Era. Neuropediatrics, 48(04), 309–314. https://doi.org/10.1055/s-0037-1603776
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Hoang Viet Krajewski, Monika Jedwabnik, Krzysztof Peszuk, Stanisław Ścigała, Aleksandra Misarko, Bartosz Olszewski, Maja Zambrzycka, Adrianna Dobrosielska, Iga Woźniakowska, Weronika Lech-Rzepinska

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 1
Number of citations: 0